drugset / Trial / NCT05011227
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Phase 2
Unknown
100 enrolled
Eye & ENT Hospital of Fudan University
Chinese Academy of Medical Sciences · collab
NaSingle-groupOpen-labelTreatment
Summary
To explore the effect of Camrelizumab and chemotherapy combining with endoscopic surgery in the treatment of recurrent nasopharyngeal carcinoma.
Timeline
- Start
- 2021-08-10
- Primary completion
- 2025-08-10
- Completion
- 2025-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Camrelizumab | Monoclonal antibody | — | — |
| Subject | Gemcitabine | Small molecule | — | — |